Aphria

Aphria’s Malta-Based Subsidiary, ASG Pharma, Receives First Import License For Cannabis Issued By The Malta Medicines Authority

Aphria’s Malta-Based Subsidiary, ASG Pharma, Receives First Import License For Cannabis Issued By The Malta Medicines Authority ASG Pharma is poised to become Aphria’s processing, manufacturing and distribution hub for the European continent

Article by Aphria Leamington, Ontario – June 21, 2018 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) today announced that its Malta-based subsidiary ASG Pharma (“ASG”), a high-capacity EU GMP-certified lab, is the recipient of the first import license for medical cannabis issued by the Malta Medicines Authority (“MMA”). The license will allow ASG to import medical cannabis for analytical testing ...

Read More »

Aphria Applauds Passage Of Bill C-45, A Historic Milestone For Canada And The Cannabis Industry

Aphria Applauds Passage Of Bill C-45, A Historic Milestone For Canada And The Cannabis Industry With annualized production of 255,000 kg, Aphria is well-prepared to meet the demand of the new adult-use market and our medical cannabis patients

Article by Aphria Leamington, Ontario – June 20, 2018 – Aphria Inc. (“Aphria” or the “Company“) (TSX: APH and US OTC: APHQF) today provided the following statement in response to the passage of Bill C-45, the Cannabis Act: Vic Neufeld, CEO of Aphria, said, “This is a historic milestone for our industry and for our country that will reverberate around the world as Canada solidifies ...

Read More »

Aphria Appoints Former Southern Glazer’s Executive Joel Toguri As Vice President Of Sales

Aphria Appoints Former Southern Glazer’s Executive Joel Toguri As Vice President Of Sales

Article by Aphria Leamington, Ontario – June 15, 2018 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) today announced the appointment of Joel Toguri as Vice President of Sales effective on June 18, 2018. Mr. Toguri joins the Company from Southern Glazer’s of Canada (“Southern Glazer’s”), where he was Vice President of Sales and Operations since 2013. “We’re ...

Read More »

Aphria Welcomes Passage Of Bill C-45 In Senate, Ready To Meet Demand For Adult-Use Cannabis In Canada

Aphria Welcomes Passage Of Bill C-45 In Senate, Ready To Meet Demand For Adult-Use Cannabis In Canada

Article by Aphria Leamington, Ontario – June 8, 2018 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) today provided the following statement in reaction to the passage of Bill C-45, the Cannabis Act, in the Senate of Canada: Vic Neufeld, CEO of Aphria, said, “Today’s passage of Bill C-45 through the Senate is a historic milestone towards safe and ...

Read More »

Aphria To Build State-of-the-Art Extraction Centre Of Excellence

Aphria To Build State-of-the-Art Extraction Centre Of Excellence Aphria increases production capacity to 255,000 kgs

Article by Aphria Leamington, Ontario – June 6, 2018 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) today announced that the company’s Board of Directors approved a $55 million capital project to build a state-of-the-art Extraction Centre of Excellence in Leamington, ON. The facility will be equipped to conduct a wide range of cannabis extractions, including C02, butane ...

Read More »

Aphria Announces $225 Million Bought Deal

Aphria Announces $225 Million Bought Deal

Article by Aphria Leamington, Ontario – June 6, 2018 – Aphria Inc. (“Aphria” or the “Company”) (TSX:APH) is pleased to announce that it has entered into an agreement with Clarus Securities Inc., on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a “bought deal” basis, 18,987,400 Common Shares (the “Common Shares”) ...

Read More »

Aphria Forms Landmark Venture With South African Company Verve Group Of Companies

Aphria Forms Landmark Venture With South African Company Verve Group Of Companies The Venture will focus on expanding the Company’s footprint in established regulated cannabis markets in Africa.

Article by Aphria Leamington, Ontario – May 28, 2018 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) today announced that it has entered into a series of agreements (the “Transaction”) resulting in Aphria forming a joint venture, CannInvest Africa Ltd. (“CannInvest”), with South African company Verve Group of Companies (“VGC”). As part of this transaction CannInvest will acquire ...

Read More »

Aphria Selects Great North Distributors, A Canadian Subsidiary Of Southern Glazer’s Wine & Spirits, For Canada-Wide Distribution Of Adult-Use Cannabis

Aphria Selects Great North Distributors, A Canadian Subsidiary Of Southern Glazer’s Wine & Spirits, For Canada-Wide Distribution Of Adult-Use Cannabis Great North Distributors to be Aphria’s exclusive cannabis representative in Canada

Article by Aphria Leamington, Ontario – May 17, 2018 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) and Great North Distributors, Inc. (“Great North Distributors”), a wholly-owned Canadian subsidiary of Southern Glazer’s Wine & Spirits (“Southern Glazer’s”) dedicated to the representation of cannabis products,  are pleased to announce today that they have signed an agreement for Great North Distributors to serve ...

Read More »

Aphria’s German Subsidiary, Nuuvera Deutschland, Aquires Interest In Berlin-Based Shöneberg Hospital

Aphria’s German Subsidiary, Nuuvera Deutschland, Aquires Interest In Berlin-Based Shöneberg Hospital Acquisition lays the foundation for nation-wide research, education and treatment activities for pain treatment centers throughout Germany

Article by Aphria Leamington, Ontario – May 17, 2018 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) today announced that its wholly-owned subsidiary Nuuvera Deutschland GmbH (“Deutschland”) has acquired a 25.1% interest in Berlin-based Schöneberg Hospital (“Schöneberg” or the “Hospital”). The acquisition facilitates Deutschland’s long-term strategy to educate German physicians and patients and advance evidence that supports the effectiveness of medical ...

Read More »

Aphria Signs Exclusive Agreement With Colombia-Based Colcanna SAS To Supply Medical Cannabis In Colombia

Aphria Signs Exclusive Agreement With Colombia-Based Colcanna SAS To Supply Medical Cannabis In Colombia

Article by Aphria Leamington, Ontario – May 16, 2018 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) today announced that it has signed an exclusive supply agreement with Colcanna SAS (“Colcanna”) a Colombia-based pharmaceutical import and distribution company, which is licensed to import, sell and distribute medical cannabis, medical products and derivatives in Colombia. “We see tremendous potential for medical ...

Read More »

Powered by Dragonballsuper Youtube Download animeshow